Jill Hall, | |
2500 Mcclellan Ave Ste 300, Pennsauken, NJ 08109-0001 | |
(609) 405-7415 | |
Not Available |
Full Name | Jill Hall |
---|---|
Gender | Female |
Speciality | Registered Nurse - Psychiatric/mental Health, Adult |
Location | 2500 Mcclellan Ave Ste 300, Pennsauken, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437716974 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WP0809X | Registered Nurse - Psychiatric/mental Health, Adult | 26NR08839300 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jill Hall, 2500 Mcclellan Ave Ste 300, Pennsauken, NJ 08109-0001 Ph: () - | Jill Hall, 2500 Mcclellan Ave Ste 300, Pennsauken, NJ 08109-0001 Ph: (609) 405-7415 |
News Archive
Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment options for brain tumour patients over the age of 70, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.
For the first time, scientists have created a satellite-guided plan to effectively control the tsetse fly - an African killer that spreads "sleeping sickness" disease among humans and animals and wipes out $4.5 billion in livestock every year.
Injuries have overtaken infectious disease as the leading cause of death for children worldwide, and psychologists have the research needed to help predict and prevent deadly childhood mishaps, according to a presentation at the annual convention of the American Psychological Association.
GlaxoSmithKline and Genmab A/S announced today an amendment to the ofatumumab co-development and commercialisation agreement. Under the terms of the amendment, GSK will take responsibility for developing ofatumumab in autoimmune indications whilst continuing to jointly develop ofatumumab with Genmab in oncology indications.
› Verified 5 days ago
George Anthony Toledo, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6650 Browning Rd Rm M19, Pennsauken, NJ 08109 Phone: 800-805-6989 | |
Fallon Nicole Woodford, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5261 Marlton Pike, Pennsauken, NJ 08109 Phone: 724-201-6351 | |
Melanie E Dito, BSN RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7100 Airport Hwy, Pennsauken, NJ 08109 Phone: 856-324-5011 Fax: 856-317-5727 | |
Elizabeth Mae Hopkins, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2500 Mcclellan Ave Ste 300, Pennsauken, NJ 08109 Phone: 856-361-1130 | |
Rita M Harder, RNC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2475 Mcclellan Ave, Pennsauken, NJ 08109 Phone: 856-675-3355 | |
Lisa Fitzpatrick-grant, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2500 Mcclellan Ave Ste 300, Pennsauken, NJ 08109 Phone: 856-361-1100 | |
Aaron Lewis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2500 Mcclellan Ave Ste 300, Pennsauken, NJ 08109 Phone: 609-496-8126 |